High-Quality Myasthenia Gravis PBMC for Research

Human Myasthenia Gravis PBMC products are sourced from donors clinically diagnosed with Myasthenia Gravis (MG) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies of autoreactive immune cells, cytokine profiling, and production of MG-associated antibodies.

Product Features

• Research Use Only (RUO), cryopreserved PBMCs
• Clinically confirmed MG donors
• Available in cell counts ranging from 5 million to 2 billion
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent
• Screen LeukoLot™ available prior to bulk orders

Donor Metadata

• Verified MG diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional Myasthenia Gravis (MG)-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in MG pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Myasthenia Gravis (MG) PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.